CIBC Private Wealth Group
HUMA icon

CIBC Private Wealth Group’s Humacyte HUMA Stock Holding History

CIBC Private Wealth Group’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$1.92K Hold
2,000
– – ﹤0.01% 2809
2025
Q3 		$3.48K Hold
2,000
– – ﹤0.01% 2640
2025
Q2 		$4.18K Hold
2,000
– – ﹤0.01% 2490
2025
Q1 		$2.3K Hold
2,000
– – ﹤0.01% 2646
2024
Q4 		$9.36K Hold
2,000
– – ﹤0.01% 2289
2024
Q3 		$10.9K Hold
2,000
– – ﹤0.01% 2380
2024
Q2 		$11.3K Buy
+2,000
New +$10.4K ﹤0.01% 2245

Other funds holding HUMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

CIBC Private Wealth Group's HUMA Position: Q4 2025 in Review

CIBC Private Wealth Group held its Humacyte (HUMA) position steady in Q4 2025 at 2,000 shares worth $1.92K. The position accounts for ﹤0.01% of the portfolio, ranked #2809.

CIBC Private Wealth Group first reported a position in HUMA in Q2 2024 and has held it in 7 quarters since. The position peaked at $11.3K in Q2 2024. 147 funds tracked by Wall St. Rank hold HUMA as of Q4 2025.

  • CIBC Private Wealth Group held 2,000 shares of Humacyte worth $1.92K as of Q4 2025.
  • CIBC Private Wealth Group left its Humacyte share count unchanged in Q4 2025.
  • Humacyte made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #2809 holding.
  • CIBC Private Wealth Group first reported a position in Humacyte in Q2 2024 and has held it in 7 quarters since.
  • CIBC Private Wealth Group's Humacyte position peaked at $11.3K in Q2 2024.
  • 147 funds tracked by Wall St. Rank held Humacyte as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.